Isolated trisomy 11 in patients with acute myeloid leukemia – Is the prognosis not as grim as previously thought?

Podobne zapisy

• Cost-effectiveness of azacitidine and venetoclax in unfit patients with previously untreated acute myeloid leukemia
  od: Patel, Kishan K., i wsp.
  Wydane: (2021)
• Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: A single center experience
  od: Bewersdorf, Jan Philipp, i wsp.
  Wydane: (2020)
• Epigenetic therapy combinations in acute myeloid leukemia: what are the options?
  od: Bewersdorf, Jan Philipp, i wsp.
  Wydane: (2019)
• Temporal patterns and predictors of receiving no active therapy among older patients with acute myeloid leukemia in the United States: A population level analysis
  od: Zeidan, Amer M., i wsp.
  Wydane: (2019)
• Polo-like kinase inhibition as a therapeutic target in acute myeloid leukemia
  od: Bewersdorf, Jan Philipp, i wsp.
  Wydane: (2021)